Patents by Inventor Ian Maxwell Shipway

Ian Maxwell Shipway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240042228
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Application
    Filed: October 11, 2023
    Publication date: February 8, 2024
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Patent number: 11819706
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: November 21, 2023
    Assignee: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Publication number: 20220176142
    Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).
    Type: Application
    Filed: February 28, 2022
    Publication date: June 9, 2022
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
  • Publication number: 20210205631
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Application
    Filed: March 22, 2021
    Publication date: July 8, 2021
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Patent number: 10981015
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: April 20, 2021
    Assignee: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Publication number: 20190111273
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 18, 2019
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Patent number: 10183172
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: January 22, 2019
    Assignee: NEURONETICS, INC.
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Publication number: 20180071544
    Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).
    Type: Application
    Filed: November 16, 2017
    Publication date: March 15, 2018
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
  • Patent number: 9849301
    Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: December 26, 2017
    Assignee: NEURONETICS, INC.
    Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
  • Publication number: 20150196772
    Abstract: A TMS device may include treatment coils and ferromagnetic components that are configured to be disposed proximate to corresponding ones of the treatment coils. The treatment coils and ferromagnetic components of the TMS device may cooperatively generate a magnetic field that exhibits one or more characteristics that differ from those of a magnetic field that is generated by the treatment coils alone. For example, the magnetic field may exhibit lower induced electrical stimulation intensity in the cranial nerves, while substantially maintaining a penetration depth into the subject's brain. In another example, the magnetic field may exhibit increased penetration depth into the subject's brain, while substantially maintaining induced electrical stimulation intensity in the cranial nerves. The TMS device may be configured to be adjustable and/or reconfigurable, for instance with respect to the anatomy of a subject (e.g., to the shape of the subject's head).
    Type: Application
    Filed: January 15, 2014
    Publication date: July 16, 2015
    Applicant: Neuronetics, Inc.
    Inventors: Kenneth Marc Ghiron, Mark Edward Riehl, Ian Maxwell Shipway
  • Publication number: 20150133717
    Abstract: A method, system, and apparatus for monitoring a magnetic field related to magnetic stimulation may be provided. A system for monitoring a pulsing magnetic field related to magnetic stimulation therapy may include a magnetic stimulation component, a sensor, and a processor. The magnetic stimulation component may be configured to generate the pulsing magnetic field for the magnetic stimulation therapy. The sensor may be configured to generate a signal associated with the pulsing magnetic field. The processor may be configured to estimate a first characteristic associated with a first peak of the signal, estimate a second characteristic associated with a second peak of the signal, and determine a third characteristic of the signal based on the first characteristic and the second characteristic. The processor may be configured to determine whether a failure occurred based on the third characteristic of the signal.
    Type: Application
    Filed: November 11, 2013
    Publication date: May 14, 2015
    Inventors: Kenneth Marc Ghiron, Ian Maxwell Shipway, Mark Edward Riehl, Ravi Pillutla
  • Publication number: 20090005729
    Abstract: Disclosed is a medical infusion device including a dedicated processing unit for detecting abnormal operation of the operation of the device. Specifically, a watchdog controller is employed as an independent monitor of the functioning of microprocessors used in the medical infusion device for controlling things such as RF communication, insulin infusion, and system integrity. Through the use of an independently-powered watchdog control system, the accuracy and reliability of the device is enhanced, resulting in greater assurance to the patient receiving periodic or continuous infusion of a drug.
    Type: Application
    Filed: June 27, 2007
    Publication date: January 1, 2009
    Applicant: Animas Corporation
    Inventors: Charles Hendrixson, Ian Maxwell Shipway, John Quinlan, Brian J. McLaughlin, Steven Getz
  • Publication number: 20080221521
    Abstract: Systems and methods for detecting an occlusion may include receiving a signal corresponding to a first force needed to deliver a first material through the tube. Furthermore, the systems and methods may include indicating that an occlusion exists if the first force is greater than a baseline value plus a delta value, the baseline value being assigned a value equal to the force necessary to deliver the first material through the tube in an un-occluded state and the delta value being assigned a value configured to create a desired level of sensitivity.
    Type: Application
    Filed: December 28, 2004
    Publication date: September 11, 2008
    Inventors: Steven P. Getz, Ian Maxwell Shipway
  • Patent number: 6656148
    Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: December 2, 2003
    Assignee: Animas Corporation
    Inventors: Kusal K. Das, Ian Maxwell Shipway
  • Publication number: 20020128594
    Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.
    Type: Application
    Filed: May 7, 2002
    Publication date: September 12, 2002
    Applicant: Animas Corporation
    Inventors: Kusal K. Das, Ian Maxwell Shipway
  • Patent number: 6423035
    Abstract: A piston-type infusion pump is provided having an improved method of occlusion detection. The infusion pump includes processing circuitry for controlling the drive mechanism to infuse medication to a patient, including a sensor to track the position of the syringe plunger, thereby metering the amount of medication dispensed to the patient. The processing circuitry also includes a force sensor for providing signals indicative of the presence of occlusions along the infusion path. The operation of the drive mechanism causes delivery of medication to the patient. The infusion pump is constructed to be watertight.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: July 23, 2002
    Assignee: Animas Corporation
    Inventors: Kusal K. Das, Ian Maxwell Shipway